Treats asthma. ANDA 90984, held by Torrent Pharmaceuticals. Montelukast Sodium.
As of Nov 21, 2026, ANDA 90984 (Montelukast Sodium), held by Torrent Pharmaceuticals, was first approved by FDA on Aug 3, 2012, with 10 approved supplements and 0 published complete response letters.
1. INDICATIONS AND USAGE Montelukast sodium tablets are a leukotriene receptor antagonist indicated for:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 3, 2012 | Original application | Approved |
| Montelukast SodiumEQ 4MG BASE · tablet, chewable;oral | Montelukast Sodium | Rx |
| Montelukast SodiumEQ 5MG BASE · tablet, chewable;oral | Montelukast Sodium | Rx |
| Apr 3, 2025 | Supplement 17Labeling · Standard review | Approved | None posted |
| Oct 15, 2021 | Supplement 16Labeling · Standard review | Approved | None posted |
| Oct 5, 2020 | Supplement 11Labeling · Standard review | Approved | None posted |
| Oct 5, 2020 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jan 4, 2016 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jan 4, 2016 | Supplement 9Labeling · Standard review | Approved | None posted |
| Apr 7, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| Aug 14, 2013 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jan 28, 2013 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 16, 2012 | Supplement 1Labeling · Standard review | Approved | None posted |
| Aug 3, 2012 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters